4.5 Review

Targeted Therapies for the Treatment of Glioblastoma in Adults

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients

Nader Sanai et al.

CLINICAL CANCER RESEARCH (2018)

Article Clinical Neurology

Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis

Elena V. Daoud et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Article Chemistry, Medicinal

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Janeta Popovici-Muller et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Meeting Abstract Oncology

Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients

David A. Reardon et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Jayashree Kalpathy-Cramer et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Article Oncology

FGFR-TACC gene fusions in human glioma

Anna Lasorella et al.

NEURO-ONCOLOGY (2017)

Editorial Material Oncology

ONC201: a new treatment option being tested clinically for recurrent glioblastoma

Marie D. Ralff et al.

TRANSLATIONAL CANCER RESEARCH (2017)

Article Oncology

Phase I trial of dovitinib (TKI258) in recurrent glioblastoma

Niklas Schaefer et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)

Article Multidisciplinary Sciences

Structural and functional features of central nervous system lymphatic vessels

Antoine Louveau et al.

NATURE (2015)

Article Oncology

Phase II study of PX-866 in recurrent glioblastoma

Marshall W. Pitz et al.

NEURO-ONCOLOGY (2015)

Correction Medicine, General & Internal

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer (vol 368, pg 2385, 2013)

[Anonymous]

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

David M. Hyman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

H. Borghaei et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Mona Meyer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Pathology

WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma

Julian Rauscher et al.

JOURNAL OF CLINICAL PATHOLOGY (2014)

Article Multidisciplinary Sciences

A vaccine targeting mutant IDH1 induces antitumour immunity

Theresa Schumacher et al.

NATURE (2014)

Letter Medicine, General & Internal

Bevacizumab for Newly Diagnosed Glioblastoma Reply

Olivier L. Chinot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma

Olivier L. Chinot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

Review Clinical Neurology

IDH1 and IDH2 Mutations in Gliomas

Adam L. Cohen et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)

Article Medicine, Research & Experimental

The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma

Brittany C. Parker et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor

Barbara Costa et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

Andrea Sottoriva et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma

Devendra Singh et al.

SCIENCE (2012)

Article Oncology

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

B. Neyns et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Editorial Material Clinical Neurology

Vaccine provides new hope for patients with deadly brain cancer

[Anonymous]

FUTURE NEUROLOGY (2010)

Article Oncology

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

David A. Reardon et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Medicine, General & Internal

IDH1 and IDH2 Mutations in Gliomas

Hai Yan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Biochemistry & Molecular Biology

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Andrew T. Parsa et al.

NATURE MEDICINE (2007)

Review Immunology

What is immune privilege (not)?

Ian Galea et al.

TRENDS IN IMMUNOLOGY (2007)

Article Oncology

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

SM Chang et al.

INVESTIGATIONAL NEW DRUGS (2005)

Review Oncology

PI3K/Akt/mTOR pathway as a target for cancer therapy

D Morgensztern et al.

ANTI-CANCER DRUGS (2005)

Article Oncology

Phase II trial of gefitinib in recurrent glioblastoma

JN Rich et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Review Immunology

Three or more routes for leukocyte migration into the central nervous system

RM Ransohoff et al.

NATURE REVIEWS IMMUNOLOGY (2003)

Article Medicine, General & Internal

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

SG O'Brien et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Oncology

The RB and p53 pathways in cancer

CJ Sherr et al.

CANCER CELL (2002)